Evidence map›Paper›PMID 15964993›Full record

ArticleGenes & development2005

Pax3/Pax7 mark a novel population of primitive myogenic cells during development.

Lina Kassar-Duchossoy, Ellen Giacone, Barbara Gayraud-Morel, Aurélie Jory, Danielle Gomès, Shahragim Tajbakhsh

Abstract read
In one paragraph

Article in Genes & development, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 241 papers.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

241 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Trunk Muscle Differentiation and Growth in Vertebrates.Results and problems in cell differentiation · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Muscle Organoid and Assembloid Systems.Advances in experimental medicine and biology · 2025
    Review
  19. Article
  20. Article

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina Kassar-DuchossoyDepartment of Developmental Biology, Pasteur Institute, Centre Nationale de la Recherche Scientifique Unité de Recherche Associeé 2578, 75724 Paris, Cedex 15, France.
Ellen Giacone
Barbara Gayraud-Morel
Aurélie Jory
Danielle Gomès
Shahragim Tajbakhsh

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle serves as a paradigm for the acquisition of cell fate, yet the relationship between primitive cell populations and emerging myoblasts has remained elusive. We identify a novel population of resident Pax3+/Pax7+, muscle marker-negative cells throughout development. Using mouse mutants that uncouple myogenic progression, we show that these Pax+ cells give rise to muscle progenitors. In the absence of skeletal muscle, they apoptose after down-regulation of Pax7. Furthermore, they mark the emergence of satellite cells during fetal development, and do not require Pax3 function. These findings identify critical cell populations during lineage restriction, and provide a framework for defining myogenic cell states for therapeutic studies.

Indexed as

AnimalsApoptosisBiomarkersDNA-Binding ProteinsGene Expression Regulation, DevelopmentalHomeodomain ProteinsMiceMice, KnockoutMice, TransgenicMuscle DevelopmentMuscle, SkeletalMyoblasts, SkeletalPaired Box Transcription FactorsPAX3 Transcription FactorPAX7 Transcription FactorTranscription FactorsBiomarkersDNA-Binding ProteinsHomeodomain ProteinsPaired Box Transcription FactorsPax3 protein, mousePAX3 Transcription FactorPax7 protein, mousePAX7 Transcription FactorTranscription Factors

Identifiers

PMID15964993
PMCPMC1151658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.